Heather Lieberman , 28, receives a COVID-19 vaccination from Yaquelin De La Cruz at the Research Centers of America in Hollywood, Florida, on August 13, 2020."[U]nder no circumstances" should US authorities approve a COVID-19 vaccine without six months of follow-up data on participants in clinical trials, a patient safety nonprofit said Wednesday.
But in comments to the FDA, the Emergency Care Research Institute says approving a vaccine with such limited data could pose "significant safety risks."There could be "very severe" consequences from rushing out a COVID-19 vaccine before clinical trials are completed, according to the Emergency Care Research Institute, a nonprofit that advises public and private health care providers on safeguarding patient safety.
The comments come as the US Food and Drug Administration is holding a teleconference on Thursday to discuss the development and authorization of a vaccine for the novel coronavirus.
Not until after the election?
Coronavirus vaccine volunteer in Brazil's AstraZeneca trial dies A volunteer in Brazil's trial of AstraZeneca's experimental coronavirus vaccine has died. The organizers said there was no reason to stop the trial - the death is not linked to the vaccine.
yeah, because FDA credibility right, like like the FDA, if they approved a vaccine before the democrats think it is ok, like like, that would be, like, so stupid...right? Pretty sure the FDA is not going to approve a vaccine that they don't think is ready - F wits...
I’m no genius but this seems like exactly what the fda should do....
Slow it down! 2024 would be just fine!
patient safety groups are only relevant when they are getting things banned
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »